Event by Novo Nordisk Foundation Science Cluster

    Conference: Harnessing airway immunity for next-gen vaccines

    The 32nd Science Cluster Conference, "Harnessing airway immunity for next-gen vaccines", will feature world leaders exploring the latest advancements in airway immunity and innovative vaccine development.

    Read more
    22-26 September 2025

    Intro

    Harnessing airway immunity represents a potentially transformative approach in the development of vaccines against respiratory infectious diseases. By focusing on generating a robust local immune response at the site of infection, next-generation vaccines may have the potential to not only prevent severe disease, but also prevent mild infections, block transmission, and establish long-term immune memory in the respiratory tract. These novel strategies aim to address some of the limitations of conventional vaccine design and testing, which has primarily focused on generating and measuring systemic rather than local immune responses. However, achieving this will require the development and implementation of new tools and a multidisciplinary approach within basic airway immunity research, vaccine design and clinical testing.

    To advance this field, innovation and evaluation of novel vaccine platforms and delivery methods that can more effectively target the airways and drive enhanced mucosal immunity will be needed. Developing high-fidelity models that accurately mimic human airway immunology and host-pathogen interactions is also crucial. Additionally, there is a gap in the field regarding standardized clinical sampling techniques and assays to evaluate the effectiveness of airway targeting vaccine strategies. Identifying new correlates of protection and addressing regulatory considerations will also play a key role in moving candidates rapidly forward through clinical development to registration.

    This conference will bring together global leaders in the airway immunology and vaccine development space. It will serve as a unique platform for researchers, biotechs, clinicians, vaccine developers, and regulators working to advance next-gen respiratory vaccines to exchange knowledge and explore the latest advancements in mucosal immunity and innovative vaccine design. The conference will also highlight the importance of bridging the current knowledge gaps through interdisciplinary collaboration. Thus, ample time will be allocated not only to presentations from leading experts, but also panel debates, networking and discussions to facilitate a deeper understanding of the needs and opportunities in the field.

    Join us to discuss recent advances and future directions as we aim to drive meaningful progress at the growing interface of airway immunology and vaccine development.

     

    Scientific Committee:

    • Thor Grundtvig Theander (Chair)
    • Henrik Nyhus Kløverpris
    • Rasmus Skaarup Mortensen
    • Teresa Lambe
    • Jakob Cramer​​
    • Kara-Lee Aves

     

    Speakers

    Andrew Steer Royal Children’s Hospital Melbourne
    Bali Pulendran Stanford University
    Carolyn King University of Basel
    Charles Richter King Next Frontier Advisors
    Chris Chiu Imperial College London
    Christine Dahlke The Coalition for Epidemic Preparedness Innovations (CEPI)
    Clara Schoeder Leipzig University
    Elisa Nemes University of Cape Town
    Erica Ollmann Saphire La Jolla Institute for Immunology
    Erin McCafrey National Institutes of Health
    Florian Krammer Icahn School of Medicine at Mount Sinai & Medical University of Vienna
    Helen McShane University of Oxford
    Ingrid Kromann The Coalition for Epidemic Preparedness Innovations (CEPI)
    Marco Cavaleri European Medicines Agency
    Marion Gruber IAVI
    Miles Davenport UNSW Sydney
    Neil King University of Washington School of Medicine
    Sarah Fortune Harvard TH Chan School of Public Health
    Shane Crotty La Jolla Institute for Immunology
    Peter Dull Gates Foundation

    Conference topics

    Conference topics

    Vaccines and airway immunity
    Vaccine development
    Translational immunology, Vaccines & delivery
    Clinical research and regulatory pathways
    Read more

    FAQ

    What will be expected of participants?

    We expect all participants to be actively present for the full duration of the conference. Moreover, we ask all approved participants with an abstract to present a poster at the conference. Lastly, the scientific committee will invite some applicants to give short talks and select particular participants to take on responsibilities throughout the conference.

    Do I have to present a poster?

    If you submitted an abstract, you were approved for the conference on the basis of your abstract and we will put up a poster wall for you. If you did not submit an abstract, we are not expecting a poster from you.

    Do I need a visa for Denmark?

    You can find more information about VISA requirementsthe "new to Denmark" website.
    Visit here: https://www.nyidanmark.dk/

    To find out if you need a visa take the following route:
    New to Denmark > Words and concepts < Countries with a visa requirement and visa-free countries

    Can i print my poster in A0 in Copenhagen?

    Yes, there is a print shop called Redhill - Det kreative kommunikationshus and they delivery to the conference center at Favrholm.

    Visit them at: https://redhill.dk/

    Can I check in at the hotel on 21st September and check out on 27th September?

    Accommodation is booked for all participants from Monday, 22 September throughout Friday, 26 September. You can check with the hotel if they have rooms available for the adjacent nights. These costs will be at your own expense. Contact: Four Points Flex or Hotel Hillerød. If you plan to do this, please inform us so we can plan accordingly.

    Alternatively, Copenhagen is only a 40min train ride away from Hillerød. You could consider staying at Copenhagen downtown.

    The shuttle bus on Friday will drop-off people in the city centre. Check out Hotel Ibsen, Generator, Steel House or citizen M.

    What is covered by the Novo Nordisk Foundation?

    Registration fee, accommodation and local costs for all approved applicants are covered by the Novo Nordisk Foundation. Only travel expenses to and from the conference venue will be at your own expense.

    When does the program start and end?

    The conference will officially commence on Monday, 22 September 2025 at 17:30 PM with a dinner and will conclude on Thursday, 25 September 2025 with a gala dinner and party. Friday, 26 September 2025 is designated as a travel day, with no official conference sessions or activities scheduled.

    Is it required to stay for the full duration of the conference?

    Yes, we expect all participants, speakers and invited profiles to stay for the full duration of the conference. The conference duration and events are designed to provide an intimite setting and a cohesive and engaging environment to establish new connections. Therefore, we kindly ask that both participants and speakers attend the conference for its entirety.